CONTROVERSIES IN MANAGEMENT .4. USE OF BETA(2) AGONISTS IN ASTHMA - MUCH ADO ABOUT NOTHING - STILL CAUSE FOR CONCERN

被引：17

作者：

TATTERSFIELD, AE

机构：

来源：

BRITISH MEDICAL JOURNAL | 1994年 / 309卷 / 6957期

关键词：

D O I：

10.1136/bmj.309.6957.794

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：794 / 795

页数：2

共 10 条

[1] SEREVENT NATIONWIDE SURVEILLANCE STUDY - COMPARISON OF SALMETEROL WITH SALBUTAMOL IN ASTHMATIC-PATIENTS WHO REQUIRE REGULAR BRONCHODILATOR TREATMENT
CASTLE, W
FULLER, R
HALL, J
PALMER, J
[J]. BRITISH MEDICAL JOURNAL, 1993, 306 (6884) : 1034 - 1037
[2] REGULAR INHALED SALBUTAMOL AND AIRWAY RESPONSIVENESS TO ALLERGEN
COCKCROFT, DW
MCPARLAND, CP
BRITTO, SA
SWYSTUN, VA
RUTHERFORD, BC
[J]. LANCET, 1993, 342 (8875) : 833 - 837
[3] CASE-CONTROL STUDY OF PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW-ZEALAND, 1977-81
PEARCE, N
GRAINGER, J
ATKINSON, M
CRANE, J
BURGESS, C
CULLING, C
WINDOM, H
BEASLEY, R
[J]. THORAX, 1990, 45 (03) : 170 - 175
[4] REGULAR INHALED BETA-AGONIST TREATMENT IN BRONCHIAL-ASTHMA
SEARS, MR
TAYLOR, DR
PRINT, CG
LAKE, DC
LI, QQ
FLANNERY, EM
YATES, DM
LUCAS, MK
HERBISON, GP
[J]. LANCET, 1990, 336 (8728) : 1391 - 1396
[5] THE USE OF BETA-AGONISTS AND THE RISK OF DEATH AND NEAR DEATH FROM ASTHMA
SPITZER, WO
SUISSA, S
ERNST, P
HORWITZ, RI
HABBICK, B
COCKCROFT, D
BOIVIN, JF
MCNUTT, M
BUIST, AS
REBUCK, AS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (08) : 501 - 506
[6] STOLLEY PD, 1972, AM REV RESPIR DIS, V105, P883
[7] VATHENEN AS, 1988, LANCET, V1, P554
[8] ASTHMA CONTROL DURING AND AFTER CESSATION OF REGULAR BETA-(2)-AGONIST TREATMENT
WAHEDNA, I
WONG, CS
WISNIEWSKI, AFZ
PAVORD, ID
TATTERSFIELD, AE
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (03): : 707 - 712
[9] BRONCHODILATOR, CARDIOVASCULAR, AND HYPOKALEMIC EFFECTS OF FENOTEROL, SALBUTAMOL, AND TERBUTALINE IN ASTHMA
WONG, CS
PAVORD, ID
WILLIAMS, J
BRITTON, JR
TATTERSFIELD, AE
[J]. LANCET, 1990, 336 (8728) : 1396 - 1399
[10] WONG CS, 1993, ROLE BETA RECEPTOR A, P201

← 1 →